Biomarker Prediction of Preeclampsia With Severe Features

Abstract

This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No. 222, Gestational Hypertension and Preeclampsia (Obstet Gynecol 2020;135:e237–60).

Original Article

^{TAGS: preeclampsia
CATEGORIES: SMFM Endorsed Partner Publication}